Welcome to PakSearch.com Pakistan's Premier Business Information
Service


For business information, annual reports, laws, ordinances, regulations and articles.




Google
 
Web Paksearch.com
United Distributors Pakistan Limited
Annual Report 2000
CONTENTS
Company Information
Notice of Annual General Meeting
Directors Report to the Shareholders
Auditors' Report to the Members
Balance Sheet
Profit and Loss Account
Cash Flow Statement
Statement of Changes in Equity
Notes to the Financial Statement
Pattern of Shareholding
COMPANY INFORMATION
BOARD OF DIRECTORS Mr. Rashid Abdulla Chief Executive
Mr. Arshad Abdulla
Mr. Khalid Malik
Mr. Tariq Ismail
Mr. Muhammed Rafi Bhatti
Mr. Haroon Rashid Ghouri
Mr. Anis Wahab Zuberi N.I.T. Nominee
COMPANY SECRETARY Mr. Muhammed Rafi Bhatti
AUDITORS Sidat Hyder Qamar & Co.
BANKERS Habib Bank Limited
Prudential Commercial Bank Limited
ABN Amro Bank
REGISTERED OFFICE 9th Floor, N.I.C. Building,
Abbasi Shaheed Road,
Karachi.
REGISTRAR Gangees Investment & Finance Consultants,
Room No. 513, 5th Floor, Clifton Centre,
Kehkashan, Block-5, Clifton,
Karachi-75600.
NOTICE OF ANNUAL GENERAL MEETING
NOTICE is hereby given that the 18th Annual General Meeting of UNITED DISTRIBUTORS
PAKISTAN LIMITED will be held at Hotel Regent Plaza, Shara-e-Faisal, Karachi on Saturday
June 30, 2001 at 11.00 a.m. to transact the following business:
1. To confirm the minutes of the last Extra Ordinary General Meeting held on December 30, 2000.
2. To receive, consider and approve the 2udited accounts or the Company for the year ended
June 30, 2000, together with the Directors' and Auditors' reports thereon.
3. To approve the cash dividend at Re. 1/-(One) per ordinary share of Rs. 10/- each (10%), as
recommended by the Directors.
4. To appoint Auditors and fix their remuneration. The Company has received a notice from a
member under section 253(1) of the Companies Ordinance, 1984 proposing M/s. Hussain
Rahman, Chartered Accountants for appointment as auditors of the Company.
5. To fix the remuneration of the full time working Directors.
6. Any other matter with the permission of chair.
By Order of the Board
Muhammed Rafi Bhatti
Karachi: May 31,2001 Company Secretary
NOTES:
1. The share transfer books of the Company will remain closed from June 28,2001 to July
05, 2001 (both days inclusive). Transfers (if any) should be received at the office of our
Registrar M/s. GANGJEES INVESTMENT & FINANCE CONSULTANTS, Room No.513,
CLIFTON CENTRE, KEHKASHAN, BLOCK 5, CLIFTON, KARACHI-75600, latest by the
close of business on Wednesday, June 27, 2001.
2. A member entitled to attend and vote at this meeting may appoint a proxy to attend and vote
on his / her behalf. A proxy need not be a member of the Company.
3. Proxies in order to be effective must be received by the Company's Registrar not less than 48
hours before the meeting.
4. Shareholders are requested to submit declaration for Zakat on the required formal and
intimate any changes in address immediately to our Registrar, M/s. GANGJEES
INVESTMENT & FINANCE CONSULTANTS, ROOM No.513, CLIFTON CENTRE,
KEHKASHAN, BLOCK 5, CLIFTON, KARACHI-75600.
CDC Account Holders will further have to follow the under-mentioned guidelines as laid down in
Circular I dated January 26, 2000 issued by Securities and Exchange Commission of Pakistan:
a) For Attending AGM
In case of individuals, the account holder and sub-account holder and/or the person
whose securities are in group account and their registration details are uploaded as per
the Regulations shall authenticate his/her identity by showing his original National Identity
Card (NIC) at the time of attending the meeting.
In case of corporate entity, the Board of Directors' resolution/power of attorney with
specimen signature of the nominee shall be produced (unless it has been provided
earlier) at the time of the meeting.
b) For Appointing Proxy
* In case of individuals, the account holder or sub-account holder and/or the person whose
securities are in group account and their registration details are uploaded as per the
Regulations, shall submit the proxy form as per the above requirement.
* Attested copies of (NIC) of the beneficial owners and the proxy shall be furnished with the
proxy form.
* The proxy shall produce his original (NIC) at the time of the meeting.
DIRECTORS REPORT TO THE SHAREHOLDERS
COMPANYS' VIEW
Before going ahead with this transaction, the Directors of your Company took the opinion from its
auditors, M/s. Sidat Hyder Qamar & Co., Chartered Accountants, wherein it was advised to the
Company about the legal matters and possible method of ascertaining the purchase price of shares.
The directors believe that the advice has been followed in letter and spirit for the equity investment
hence due compliance was made with regard to the transactions legality and professional views.
The management acted in the light of expert opinion given by the auditors, with due care and
diligence within the legal and professional frame work and with the precision in factors forecasting
with the objectives of improving and cementing trade & business relationship with the multinational
organizations and global leaders in the agro pesticides and chemical business to improve the
profitability of the Company.
* In the light of opinion given by the auditors, it was ensured that the parties to the transaction are
not related to each other.
* In determination of share price at Rs. 49/- and quantification of share premium at Rs. 39/- per
share the management fully considered the guidelines proposed by the auditors in their opinion.
* The management of UDPL ensured that fair market value of D.E. United shares was at Rs. 49/-
per share and a premium of Rs. 39/- per share was negotiated after careful review of the
followings factors:-
* Fair market monetary value of the shares was made in accordance with the current
methods of Company valuation.
* Future projection plans of joint venture were considered.
* Profitability of the Company i.e. in accounting year ended 30-06-1999 was considered.
* Break-up value if the shares as on 30-06-1999 was considered.
* General reputation of DAS.
* Major discovery of product likely to enhance the Companys' future sale was also taken
into account.
* Government efforts to increase crop protection were also considered in the light of new
avenues for future growth and expansion.
* Partners, i.e. DAS and UDPL confidence in BDAS/DEU were reviewed.
* The management believes that purchase price of shares at Rs. 49/- per share determined and share
premium quantified at Rs. 39/- per share was an arms length and bonafide transaction and it is
accordingly recorded in the books of accounts and disclosed in the financial statements as at
June 30, 2000 in conformity with the provisions of the Companies Ordinance, 1984 and the related
accounting standards.
* The management has concluded that the Auditors have provided the company with an opinion on
December 29,1998 with reference to the specific transaction in the light of legal provisions and
the management relying on the same acted upon it. A professional firm of accountants therefore
should be consistent in forming an opinion on a matter both in the capacity of an advisor and an
auditor. The opinion expressed on the 2000 financial statements is not consistent and is based on
a complete misunderstanding of the facts of the matters.
* An EGM was held on 30-12-2000 in which the directors of your Company also had the
opportunity to explain the above investments and the short-term objectives of the disposal of the
investments. This is also referred in note 11.1. Therefore, directors are confident that both the
purchase and sale transactions have been made with due consensus and in the best interest of the
Company and its shareholders.
* In recommending dividend for the year 2000, Directors opined that since company earned a profit
and earning per share was Rs. 1.67/- as disclosed in the Profit and Loss account, the shareholder
should be benefited. The view expressed by the auditors in para(b) of their report was not relevant
since loss was temporary and provisions was not necessary in view of the safeguard available to
the Company as disclosed in Note 11.1 and benefits stated hereunder.
* The matter of compliance of Section 208 of the Companies Ordinance, 1984 has been explained
in note 11.1.
BENEFITS OF UDPL, DOW & BAYER JOINT VENTURE
The management of your Company made the decision to acquire shares of D.E. United (Pvt.) Limited
and subsequently enter into restructured transaction based on a business decision to the benefit of the
shareholders of the Company. Apart from the monetary gain, the Company also benefited
substantially as elaborated below by acquiring rights to distribute the products and significantly
increases its profitability.
* The goodwill of both Bayer AG and Dow AgroSciences is globally accepted and recognized
coupled with on going research and development of these Companies in new products and
measure for pest controls has great potentials for revenue.
* The joint venture of UDPL with these two recognized multinationals in the name & style of
BAYER, DOW and UDPL will not only result in long term benefit to the shareholders of each of
the joint venture partners but will also shape new dimensions in the agricultural pest management
in Pakistan.
* Currently, all the major pesticide, being market in Pakistan are imported from abroad, by forming
a joint venture representing two (2) of the world leading multinational pesticide manufactures and
UDPL a leading pesticide marketing company in Pakistan will result, that in most modest term,
may called the beneficial bond for the shareholders of UDPL being the joint venture partners of
BAYER and DOW AGROSCIENCES (BDAS).
Other short term future benefits of this joint venture arrangement, may be classified as under:-
a) Equity Benefits
b) Revenue Benefits
c) Administrative Benefits
The Directors take pleasure in submitting their report and audited accounts of the Company for the
year ending June 30, 2000.
FINANCIAL RESULTS 2000 1999
The net profit of the Company for the year before taxation 14,847,295 16,664,958
Provision for taxation - current year 3,800,000 3,000,000
------------------ ------------------
Profit after taxation 11,047,295 12,544,958
Un-appropriated Profit brought forward 3,504,539 12,959,581
------------------ ------------------
Profit available for appropriation 24,551,834 25,504,539
Less :Appropriations:
Dividend @ 10% (1999: @ 10%) 6,600,000 6,600,000
Transfer to Reserve for
Issue of Bonus Shares -- 6,600,000
------------------ ------------------
6,600,000 12,000,000
------------------ ------------------
Rupees 17,951,834 13,504,539
========== ==========
Earning per share 1.67 1.90
========== ==========
REVIEW OF OPERATIONS
In the year ending June 30, 2000 the Company's turnover was Rs. 59.64 million as compared to the
previous Rs. 126.52 million for the ending June 30, 1999.
The reasons for decline in sales are as follows:
a) During the current cotton season the overall pest pressure was comparatively low which resulted
in lower sales of pesticides.
b) Nichimen's products, which are being marketed by us, were discontinued during the year.
c) Decrease in the overall sales of pesticides also resulted decline in distribution fee for the products
handled by the company for our joint venture partners.
INVESTMENT IN JOINT VENTURE
The long-term investment in equity shares of the D.E. United (Private) Limited and its disposal in the
subsequent period has been subject to the considered decisions by management. These decisions were
objectively evaluated in a potential business perspective and as a going concern. During the course of
audit, management has had a series of meetings and discussions with the auditors in which auditors
were appraised about the salient features of management decisions. Further, all relevant
documentation and representations were also provided. However, auditor maintained their
apprehensions and did not take a note of foreseeable business opportunities available for both to the
investee and your Company.
AUDITORS' VIEW
The auditors in their report stated that:-
1. As stated in note 11.1 to the financial statements, during the year, the Company, under an
agreement, purchased from a related party 1,846,647 Ordinary Shares of the face value of
Rs. 10/- each of Bayer DAS (Private) Limited (formerly D.E. United (Pvt.) Ltd.) at a price of Rs. 49/-
per share aggregating Rs. 90,485,703/-. The said related party was stated to be the seller at the
time of acquisition, although, these shares were held by another related party at that time on the
records of the investee company.
The aforesaid acquisition cost of Rs. 49/- per share, in our opinion, was considerable high and did
not represent a fair value of such shares when viewed in the context of Rs. 20.83 per share being
the break-up value thereof based on the audited financial statements of the investee company for
the year ended 30th June 1999 and the financial projections on which reliance is stated to have
been placed by the Company at the time of acquisition.
Subsequent to the balance sheet date, the Company has sold the entire aforesaid shares to a third
party at a mutually agreed consideration of Rs. 2.94/- per share, thus resulting in a loss of
Rs. 85,056,560/-, for which no provision has been made in these accounts. The need for a provision
of Rs. 85,056,560/-, for the loss is evidenced by the fact that the break-up value of such shares as
at the balance sheet date i.e. 30th June 2000.
The fact and the manner in which the said shares were acquired from a related party at a price
considerably higher than its fair value coupled with the peculiar terms and conditions governing
the transactions as stated in note 11.1 to the financial statements leads us to believe that the
acquisition was neither at arm's length nor bonafide.
In the meeting of the Board of Directors of the Company held on 31 May 2001, a cash dividend
of Rs. 1/- per Ordinary share of Rs. 10/- each has been recommended to be declared. In view of
our qualification on the financial statements as stated above, had the provision of
Rs. 85,056,560/- been made, the accumulated reserve before appropriation as of the balance sheet
date would have converted into accumulated loss of Rs. 40,504,726/-. Consequently, in the
absence of profit available for distribution, the dividend as proposed, in our opinion is, in terms of
the provisions of the Companies Ordinance, 1984, out of capital and hence ultra vires the
provisions of the said Ordinance.
2. We draw attention to the fact that Section 208 of the Companies Ordinance, 1984 (the Ordinance)
restricts a Company from making investment in associated companies exceeding thirty percent of
its paid-up share capital plus free reserves at any point of time. The paid-up share capital and
reserves of the Company as at 30th June 2000 before the impact of the matter as referred to in
paragraph (a) above were Rs. 66 million and Rs. 37.952 million respectively, aggregating
Rs. 103.952 million, against which, the investment made by the Company in associated companies is
to the extent of 112.7% thereof as at that date.
a) Equity Benefits
Dow AgroSciences will cover UDPL's obligation for the immediate capital injection, which is
expected between 1.2 Million USD to 1.5 Million USD.
UDPL will at a later stage, when legally possible, purchase 50% of Dow AgroSciences share for
100,000 USD. If the value of the D.E. United is growing with x% the selling price from Dow
AgroSciences will increase proportionately based on the date of each fresh capital injection.
Currently, there is a negative equity in D.E. United amounting to approx. 1 Million USD as at
June 30, 2000. As a part of the proposed partnership, Dow AgroSciences shall inject for the time being
sufficient amount (equivalent to 1 Million USD) to wash out the negative equity. This injection of
equity on behalf of UDPL shall be made free of any charge, interest or markup.
DAS has already invested in BDAS, US$ 700,000 equivalent to Pak. Rs. 37,570,000/- on December
30, 2000.
UDPL will get 25% of DAS shareholdings in BDAS on January 1, 2003 equivalent to 2,801,825
shares as against 1,846,650 shares temporarily sold to BAYER.
UDPL DAS BAYER TOTAL
Shareholding on 29-12-2000 1,846,650 1,846,650 -- 3,693,300
Shareholding on 30-12-2000 -- 3,757,000 -- 3,757,000
Shareholding on 16-03-2001 (1,846,650) -- 1,846,650 --
Shareholding on 17-03-2001 -- -- 3,757,000 3,757,000
------------------ ------------------ ------------------ ------------------
TOTAL SHAREHOLDING BDAS -- 5,603,650 5,603,650 11,207,300
Shareholding on 01-01-2003 2,801,825 (2,801,825) -- --
========== ========== ========== ==========
NEW SHAREHOLDING IN BDAS 2,801,825 2,801,825 5,603,650 11,207,300
========== ========== ========== ==========
b) Revenue Benefits
UDPL being the sole distributor of BDAS for Pakistan gets a distribution fee for the services
provided to BDAS. By induction of Bayer AG in D.E. United, the span of distribution services
provided by UDPL will become almost double and there will be a substantial increase in the revenues
of UDPL, mainly in the area of Distribution fee for production handling which is expected to increase
by 150% as a consequence of this partnership.
Besides this, the additional equity injection, without any interest, markup or charge as stated in equity
benefits above, shall result in saving of financial charges to a minimum of an amount equivalent to
50% of the distribution fee for product handling of UDPL for the year ending June 30, 2000.
In the year ending June 30, 1999, the pre tax profit of DEU showed a decline only because of the
financial charges on borrowed capital for future expansion. This availability of equity without
financial charges will enable DEU to recoup its past losses and thereby strengthening its financial
base, which will ultimately benefits the joint venture partners and their respective shareholders.
c) ADMINISTRATIVE BENEFITS
As a part of the new arrangement, all the joint venture partners agree that UDPL shall take an active
role as a future potential partner guiding the Company mainly with regards to:
* Development of strategies
* Selection of appropriate key managers
* Preparation of annual budgets
This sharing of knowledge & expertise in the areas stated above with two of the leading
multinationals, will provide a new window to the UDPL to acquire their knowledge, expertise and
strategies and to apply them locally for the benefit of its shareholders.
Additionally, UDPL being one of the leading distribution marketing company in Pakistan, will also
benefit the partnership by sharing its knowledge and proposed strategies for marketing in the local
environment, thereby becoming an equal contributor in the efforts expanded by the joint venture
partners for earning the revenues.
FUTURE OUTLOOK
We have now restructured the Company and are hopeful of regaining our position with the marketing
of our own brands and also by expanding our physical distribution services provided to our joint
venture partners. The span of distribution services provided by your Company will increase
substantially mainly in the area of distribution fee for product handling as a consequence of new
partnership agreements with our joint venture partners.
Your Company has been approached by a leading International Company, for distributing/marketing
their range of products which mainly include Fungicides, Miticides and Insecticides.
Your Company is in the process of finding new seed business who have a long-term vision of staying
in the Pakistan market. This would help to regenerate the seeds business and thereby increase our
sales volumes and profitability.
HOLDING OF SHARES
The pattern of holding of shares is shown on page 34.
ACKNOWLEDGMENT
The Directors of your Company take great pleasure in recording their appreciation of the fine work
put in by all Company staff during the last year.
RASHID ABDULLA
Karachi: May 31, 2001 CHIEF EXECUTIVE
AUDITORS' REPORT TO THE MEMBERS
We have audited the annexed balance sheet of UNITED DISTRIBUTORS PAKISTAN LIMITED as
at 30 June 2000 and the related profit and loss account, cash flow statement and statement of changes in
equity together with the notes forming part thereof, for the year then ended and we state that we have
obtained all the information and explanations which, to the best of our knowledge and belief, were
necessary for the purposes of our audit.
It is the responsibility of the Company's management to establish and maintain a system of internal
control, and prepare and present the above said statements in conformity with the approved accounting
standards and the requirements of the Companies Ordinance, 1984. Our responsibility is to express an
opinion on these statements based on our audit.
We conducted our audit in accordance with the auditing standards as applicable in Pakistan. These
standards require that we plan and perform the audit to obtain reasonable assurance about whether the
above said statements are free of any material misstatement. An audit includes examining, on a test basis,
evidence supporting the amounts and disclosures in the above said statements. An audit also includes
assessing the accounting policies and significant estimates made by management, as well as, evaluating
the overall presentation of the above said statements. We believe that our audit provides a reasonable
basis for our opinion and, after due verification, we report that:
(a) As stated in note 11.1 to the financial statements, during the year, the Company, under an agreement
purchased from a related party 1,846,647 Ordinary shares of the face value of Rs. 10/-
each of Bayer DAS (Private) Limited [Formerly D.E. United (Private) Limited] at a price of
Rs. 49/- per share aggregating Rs.90,485,703/-.The said related party was stated to be the seller at
the time of acquisition, although, these shares were held by another related party at that time on
the records of the investee company.
The aforesaid acquisition cost of Rs. 49/- per share, in our opinion, was considerably high and did
not represent a fair value of such shares when viewed in the context of Rs. 20.83 per share being
the break-up value thereof based on the audited financial statements of the investee company for
the year ended 30 June 1999 and the financial projections on which reliance is stated to have been
placed by the Company at the time of acquisition.
Subsequent to the balance sheet date, the Company has sold the entire aforesaid shares to a third
party at a mutually agreed consideration of Rs. 2.94/- per share, thus resulting in a loss of
Rs. 85,056,560/-, for which no provision has been made in these accounts. The need for a
provision of Rs. 85,056,560/- for the loss is evidenced by the fact that the break-up value of such
shares as at the balance sheet date i.e. 30 June 2000 was negative.
The fact and the manner in which the said shares were acquired from a related party at a price
considerably higher than its fair value coupled with the peculiar terms and conditions governing
the transactions as stated in note 11.1 to the financial statements leads us to believe that the
acquisition was neither at arm's length nor bonafide.
(b) In the meeting of the Board of Directors of the Company held on 31 May 2001, a cash dividend
of Re. 1/- per Ordinary share of Rs. 10/- each has been recommended to be declared. In view of
our qualification on the financial statements as stated in paragraph (a) above, had the provision of
Rs.85,056,560/- been made, the accumulated reserves before appropriation as of the balance
sheet date would have converted into accumulated loss of Rs. 40,504,726/-. Consequently, in the
absence of profit available for distribution, the dividend as proposed, in our opinion is, in terms of
the provisions of the Companies Ordinance, 1984, out of capital and hence ultra vires the provisions
of the said Ordinance.
(c) In our opinion, proper books of account have been kept by the Company as required by the
Companies Ordinance, 1984;
(d) In our opinion:
(i) the balance sheet and profit and loss account together with the notes thereon have been
drawn up in conformity with the Companies Ordinance, 1984, and are in agreement with
the books of account and are further in accordance with accounting policies consistently
applied;
(ii) the expenditure incurred during the year was for the purpose of the Company's business; and
(iii) the business conducted, investments made and the expenditure incurred during the year
were in accordance with the objects of the Company except for the matter stated in
paragraph (a) above and the